Genpact SVP granted 16,530 RSUs in Form 4

Genpact Limited Senior Vice President Sameer Dewan reported an equity award of 16,530 common share units on January 30, 2026.

Rhea-AI Filing Summary

Genpact Limited Senior Vice President Sameer Dewan reported an equity award of 16,530 common share units on January 30, 2026. The filing shows these shares at a price of $0, reflecting a grant of unvested restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Each RSU converts into one Genpact common share as it vests. One-third of the award will vest on each of January 10, 2027, January 10, 2028, and January 10, 2029, contingent on continued service. Following this grant, Dewan beneficially owns 54,279 common shares directly.

Insider Trade Summary

Grant/Award: 16,530 shares

Grant/Award 1 txn

Insider Dewan Sameer

Role Senior Vice President

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	16,530	$0.00	$0.00

Holdings After Transaction: Common Shares — 54,279 shares (Direct)

Footnotes (1)

1. F1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sameer Dewan report for Genpact (G)?

Sameer Dewan reported receiving 16,530 Genpact common share units as an equity grant on January 30, 2026. The award consists of unvested restricted share units that convert into common shares upon vesting, granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

How many Genpact (G) shares does Sameer Dewan own after this Form 4 transaction?

After the reported grant, Sameer Dewan beneficially owns 54,279 Genpact common shares directly. This total includes the newly awarded 16,530 restricted share units, which entitle him to receive an equal number of common shares as the units vest over time.

What are the vesting terms of Sameer Dewan’s 16,530 Genpact RSUs?

The 16,530 RSUs vest in three equal installments, with one-third vesting on January 10, 2027, one-third on January 10, 2028, and one-third on January 10, 2029. Vesting depends on Dewan’s continued service with Genpact through each specified vesting date.

What price per share is shown for Sameer Dewan’s Genpact RSU award?

The Form 4 reports a transaction price of $0 per share for the 16,530 common share units. This reflects that the units were granted as equity compensation rather than purchased in the open market, consistent with awards under an incentive compensation plan.

What position does Sameer Dewan hold at Genpact (G) in this filing?

In this filing, Sameer Dewan is identified as a Senior Vice President of Genpact Limited. The Form 4 box for officer is checked, and his title is specified, indicating the reported equity award is tied to his role as a company executive.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:03 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dewan Sameer

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/30/2026		A		16,530(1)	A	$0	54,279	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Sameer Dewan	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.